IDH1 and glioblastoma: IDH1 mutations were found to increase HIF-1α and VEGF serum levels in primary GBM and contribute to oncogenesis through the induction of the HIF-1α pathway in primary GBM, even under normoxia, a process named “pseudohypoxia” [44,45] (Table 3, Fig. 2).